S&P 500 Futures
(0.05%) 5 539.50 points
Dow Jones Futures
(-0.11%) 39 484 points
Nasdaq Futures
(0.20%) 20 012 points
Oil
(0.93%) $81.58
Gas
(-2.10%) $2.70
Gold
(-0.39%) $2 321.60
Silver
(0.28%) $28.95
Platinum
(1.24%) $998.60
USD/EUR
(0.30%) $0.936
USD/NOK
(0.21%) $10.63
USD/GBP
(0.20%) $0.790
USD/RUB
(-0.28%) $87.25

Echtzeitaktualisierungen für Verastem Inc [VSTM]

Börse: NASDAQ Sektor: Healthcare Industrie: Biotechnology
Zuletzt aktualisiert25 Jun 2024 @ 22:00

-5.16% $ 2.94

Live Chart Being Loaded With Signals

Commentary (25 Jun 2024 @ 22:00):
Our systems believe the stock currently is undervalued by 0.41% compare to its pairs and should correct upwards.

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK...

Stats
Tagesvolumen 548 583
Durchschnittsvolumen 689 630
Marktkapitalisierung 74.46M
EPS $-1.260 ( Q1 | 2024-05-09 )
Nächstes Ertragsdatum ( $-1.030 ) 2024-08-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.690
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0100 (0.34%)
AADI -2.86%
ABCL -2.15%
ABCM 0.04%
ABEO -2.99%
ABIO 2.29%
ABOS -4.46%
ABSI -3.29%
ABUS -0.65%
ABVX -3.34%
ACAD -1.76%
ACER -17.95%
ACET -2.00%
ACGN 1.29%
ACHL 1.43%
ACHV -1.90%
ACIU -3.37%
ACLX -4.07%
ACRV -3.19%
ACST -3.13%
ACXP -4.82%
ADAG -3.08%
ADAP -1.67%
ADGI 0.87%
ADIL -0.87%
ADMA 0.00%
ADPT 3.04%
ADTX 1.13%
ADVM 1.02%
ADXN -1.60%
AEON 5.94%
AEZS 0.22%
AFMD -3.54%
AGEN -2.36%
AGIO -1.19%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -5.20%
AKRO -1.47%
AKTX -25.54%
AKUS 0.00%
ALBO 0.00%
ALDX 1.22%
ALEC -5.01%
ALGS -6.06%
ALKS -1.83%
ALLK -1.67%
ALLO -8.05%
ALLR -34.80%
ALNA 3.16%
ALNY 7.74%
ALPN 0.02%
ALPX 0.00%
ALRN -1.64%
ALT 3.78%
ALVR -1.01%
ALXN 0.00%
ALXO 0.31%
ALZN -2.08%
AMRN 2.72%
AMTI -3.13%
ANAB -0.83%
ANEB 4.87%
ANGN 0.00%
ANIX -1.20%
ANL -3.22%
ANNX -3.98%
ANPC -3.15%
APGE -3.92%
APGN 8.48%
APGNW 30.65%
APLM -3.77%
APLS 5.15%
APLT -4.10%
APM 1.06%
APOP 0.38%
APRE 0.24%
APTO -1.43%
APTX 3.17%
APVO -6.12%
ARAV -13.39%
ARCT -3.88%
ARDS 2.28%
ARDX -3.68%
ARGX 2.49%
ARNA 0.00%
ARPO -0.90%
ARQT 8.11%
ARTL 11.29%
ARTLW 0.00%
ARVN -2.04%
ARWR -1.36%
ASLN -2.08%
ASMB -1.91%
ASND 4.95%
ATAI -3.57%
ATHA -7.59%
ATHE -0.83%
ATHX -33.50%
ATNF -0.66%
ATOS -3.74%
ATRA -6.10%
ATXI -2.72%
ATXS -1.74%
AUPH -1.59%
AURA -4.22%
AUTL -6.45%
AVBP -2.13%
AVEO 0.00%
AVIR -1.72%
AVRO -1.41%
AVTE -3.33%
AVTX 3.46%
AVXL -3.80%
AXLA 0.00%
AXSM 0.65%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.65%
BCAB -1.92%
BCDA 3.53%
BCDAW -39.75%
BCEL 0.00%
BCLI 3.13%
BCRX -3.03%
BCTX -13.88%
BCTXW -4.44%
BCYC -2.58%
BDRX -2.01%
BDTX -3.89%
BEAM -2.34%
BFRA -2.91%
BGNE -5.13%
BIOR -2.10%
BIVI -5.32%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -5.71%
BLTE -0.27%
BLU 0.03%
BLUE -7.08%
BMEA -6.13%
BMRN -0.20%
BNOX -9.25%
BNTC 0.00%
BNTX -2.57%
BOLD -18.11%
BOLT 0.18%
BPMC 0.42%
BPTH 0.48%
BPTS -13.47%
BRNS 0.74%
BRTX 2.91%
BTAI -0.84%
BTTX 1.35%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI -5.22%
CABA -13.47%
CADL -8.13%
CALA 0.00%
CALC 0.00%
CALT -1.18%
CAPR -3.13%
CARA -2.56%
CARM 2.68%
CASI -4.74%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.86%
CCCC 0.00%
CCXI 0.00%
CDAK 0.00%
CDIO -8.01%
CDIOW 24.00%
CDMO -1.53%
CDMOP 0.04%
CDT -15.17%
CDTTW -39.60%
CDTX 5.75%
CDXC -4.31%
CDXS -3.33%
CELC -1.02%
CELU -2.60%
CELUW 11.80%
CERC -1.68%
CERE -4.49%
CERO -14.81%
CEROW 0.60%
CFRX -27.95%
CGEM -5.47%
CGEN -3.21%
CGON -1.47%
CGTX -4.86%
CHMA -6.00%
CHRS -3.07%
CINC 0.00%
CING -3.46%
CINGW 34.95%
CKPT 0.48%
CLBS -16.75%
CLDX 0.11%
CLGN 0.59%
CLLS 1.05%
CLNN -5.91%
CLNNW 0.00%
CLRB -5.59%
CLSD 15.74%
CLSN -0.68%
CLVS 0.00%
CMMB 2.45%
CMND -7.46%
CMPI 0.00%
CMPX -4.50%
CMRA 0.00%
CMRAW 33.33%
CMRX 2.05%
CNCE 0.00%
CNSP 27.35%
CNST 0.00%
CNTA 0.00%
CNTB -3.62%
CNTX 0.46%
COCP -7.20%
COEPW 32.45%
COGT -6.41%
CORT -0.65%
COYA 4.24%
CPRX -1.56%
CRBP 1.93%
CRBU -5.88%
CRDF -4.24%
CRGX -4.30%
CRIS -4.39%
CRNX -1.73%
CRSP -3.43%
CRTX 2.63%
CRVO 0.00%
CRVS -2.73%
CSBR -1.59%
CTCX -11.35%
CTIC 0.06%
CTMX -9.02%
CTNM 3.86%
CTXR 5.10%
CUE -1.70%
CVAC 2.02%
CVKD -2.39%
CWBR 2.80%
CYAD -12.96%
CYCC -4.79%
CYCCP 5.49%
CYCN 5.02%
CYT -2.27%
CYTK -1.91%
CYTO -6.78%
DARE -2.35%
DAWN -0.96%
DBTX -0.81%
DBVT 0.91%
DFFN 10.28%
DICE 0.06%
DMAC 1.80%
DNLI -2.27%
DNTH -5.02%
DOMH 2.16%
DRMA -6.21%
DRMAW -1.25%
DRNA 0.00%
DRTS -1.82%
DRTSW 0.00%
DRUG 5.61%
DSGN -1.49%
DTIL 0.95%
DYAI -3.13%
EARS -1.77%
EDIT -2.17%
EDSA -3.71%
EFTR -1.06%
EFTRW 145.45%
EIGR -9.21%
ELAB -1.03%
ELDN -8.81%
ELEV -1.63%
ELOX -7.14%
ELTX -4.76%
ELVN -1.69%
ELYM -5.28%
ENGN -0.37%
ENGNW 18.81%
ENLV -3.55%
ENOB 1.79%
ENSC -3.98%
ENTA 0.25%
ENTO 1.69%
ENTX -9.22%
ENVB -7.29%
EPIX 0.00%
EPRX -2.97%
EPZM 0.00%
EQ 0.46%
EQRX -2.09%
EQRXW 0.00%
ERAS -3.70%
ERNA -1.64%
ERYP 1.30%
ESLA -0.65%
ESLAW 87.05%
ETNB -6.98%
ETON -1.20%
ETTX 0.00%
EVAX 6.44%
EVGN 0.58%
EVLO 0.00%
EWTX 4.07%
EXAI 0.95%
EXEL -0.27%
EYEG 0.04%
EYEN -2.23%
EYPT -3.05%
FATE -3.13%
FBIO -0.59%
FBIOP 0.32%
FBLG 0.00%
FBRX -6.12%
FDMT -5.38%
FENC -2.36%
FGEN -2.50%
FHTX -1.50%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -1.30%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -2.26%
FULC -5.68%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 4.69%
GANX 0.78%
GBIO 1.43%
GBT 0.01%
GDTC -1.45%
GERN -1.53%
GHRS 0.84%
GLMD -2.79%
GLPG -2.10%
GLSI -0.77%
GLTO -6.44%
GLUE -0.52%
GLYC 25.28%
GMAB -0.15%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.81%
GNLX -0.88%
GNPX 0.99%
GNTA 3.94%
GOSS 22.26%
GOVX -27.39%
GOVXW -49.04%
GPCR -8.52%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -3.41%
GRTX 12.03%
GTHX -0.90%
GUTS -9.22%
GXGXW 41.67%
GYRE -3.78%
HALO 0.65%
HARP 0.09%
HCWB -1.65%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -2.68%
HOOK 0.30%
HOTH -4.46%
HOWL -10.34%
HRMY -0.07%
HRTX -4.09%
HSTO 0.00%
HUMA -3.33%
HUMAW 1.27%
IBRX -0.95%
ICCC 0.22%
ICPT 0.21%
ICU -19.90%
ICUCW -13.76%
ICVX -0.91%
IDRA -23.04%
IDYA -2.38%
IFRX -2.99%
IGMS -6.44%
IKNA 0.00%
IKT 0.40%
IMAB 0.00%
IMCR -1.09%
IMGN 0.02%
IMGO 0.00%
IMMP -1.13%
IMMX 1.75%
IMNM -3.35%
IMNN 2.34%
IMPL -27.27%
IMRA 15.96%
IMRN 0.00%
IMRX -4.03%
IMTX -1.64%
IMTXW 6.00%
IMUX -1.82%
IMV 0.00%
IMVT -0.29%
INAB 1.54%
INBX -2.46%
INCY -1.02%
INDP -1.80%
INFI -52.38%
INKT -1.11%
INM -6.35%
INMB -5.05%
INO -3.39%
INSM 1.87%
INTS 0.20%
INVA 0.88%
INZY -2.46%
IOBT 6.72%
IONS 5.19%
IOVA 3.55%
IPA 0.00%
IPHA -1.72%
IPSC -4.48%
IRON -1.04%
ISEE 0.38%
ITOS -1.81%
ITRM 3.42%
IVA 6.96%
IVVD -4.72%
JAGX 0.53%
JANX -4.05%
JAZZ -1.59%
JNCE 0.00%
JSPR -5.33%
JSPRW -16.18%
JUNS 0.00%
JUNSW 0.00%
KA -13.66%
KALV -1.45%
KDNY 0.22%
KMPH -0.34%
KNSA 0.53%
KNTE -0.38%
KOD -7.33%
KPRX 2.21%
KPTI -0.91%
KRBP -10.00%
KRON -6.43%
KROS -1.79%
KRRO -4.81%
KRTX 0.03%
KRYS 1.37%
KTRA 13.76%
KTTA 8.16%
KTTAW 0.92%
KURA -2.80%
KYMR -0.95%
KYTX -1.90%
KZIA -12.30%
KZR 0.97%
LABP 0.57%
LBPH -2.31%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.00%
LENZ -2.43%
LEXX -2.26%
LEXXW -14.63%
LGND -1.33%
LGNDV 0.00%
LGVN -2.08%
LIAN -8.28%
LIFE 2.70%
LIPO -23.38%
LIXT 0.77%
LIXTW -42.57%
LJPC -0.32%
LMNL 0.12%
LOGC 2.68%
LPCN -12.37%
LPTX -3.19%
LQDA -2.54%
LRMR -3.50%
LSTA 3.21%
LTRN 2.56%
LUMO -1.32%
LVTX 3.19%
LXEO -0.76%
LXRX -6.08%
LYEL -3.77%
LYRA -1.79%
MACK 0.10%
MBIO -12.31%
MBRX -0.71%
MCRB -1.11%
MDGL -1.39%
MDNA -13.16%
MDWD 0.55%
MDXG -0.15%
MEIP 2.88%
MESO -0.59%
MGNX -4.67%
MGTA -7.74%
MGTX -1.17%
MGX 3.61%
MIRM -4.91%
MIRO 0.59%
MIST -7.19%
MITO 0.00%
MLEC 7.41%
MLECW 23.81%
MLND -5.36%
MLTX 2.56%
MLYS -3.64%
MNKD -3.50%
MNMD -4.20%
MNOV 2.16%
MNPR 2.63%
MOLN 0.97%
MOR -1.71%
MORF 6.79%
MREO -6.91%
MRKR -1.49%
MRNA 0.44%
MRNS -0.73%
MRSN -4.98%
MRTX -0.17%
MRUS -0.23%
MRVI -2.83%
MTCR -1.29%
MTEM -2.88%
MTP -18.50%
MURA 0.31%
MYMD -1.60%
NAMS 0.20%
NAMSW 0.43%
NAUT 0.67%
NBRV 0.71%
NBSE -1.56%
NBTX 11.93%
NCNA -5.00%
NERV -2.15%
NEXI -1.06%
NGM -1.28%
NGNE -2.05%
NKGN 0.00%
NKGNW 8.00%
NKTR -8.55%
NKTX 9.46%
NLSP -7.12%
NLSPW 26.67%
NMRA -7.89%
NMTR -42.97%
NOVN -24.84%
NRBO 4.41%
NRIX -1.09%
NRSN 1.06%
NRSNW 0.00%
NRXP 0.75%
NRXPW 27.78%
NRXS -2.73%
NTBL -11.13%
NTEC -12.45%
NTHI 0.00%
NTLA -4.00%
NTRBW -31.07%
NUVL -0.30%
NVAX -0.14%
NVCT -1.39%
NVIV -34.28%
NXTC 1.19%
NYMX -0.05%
OABI -6.65%
OABIW -10.06%
OBIO -0.58%
OBSV 0.00%
OCEA 2.16%
OCGN -6.35%
OCS -0.30%
OCUL 0.46%
OCUP -4.38%
ODT -4.27%
OKYO -4.13%
OLMA -1.26%
OMER -4.77%
OMGA -0.83%
ONCO -2.22%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.00%
ONTX -0.47%
ONVO -5.06%
OPNT 0.00%
OPT -1.03%
ORGS -1.66%
ORIC -5.73%
ORMP 0.45%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -3.10%
OVID -11.39%
OYST 0.00%
PALI -3.25%
PASG 0.22%
PBLA 0.00%
PBM -4.22%
PBYI 1.37%
PCSA 6.92%
PCVX -1.69%
PDSB 10.49%
PEPG -6.00%
PGEN 3.73%
PHAR -6.99%
PHAS 0.00%
PHAT -4.62%
PHIO 2.30%
PHIOW 36.47%
PHVS 7.54%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -3.79%
PLUR -5.45%
PMN -5.66%
PMVP -0.59%
PNT 0.16%
PPBT -7.68%
PRAX -6.28%
PRDS 0.93%
PRLD -3.56%
PROG -3.47%
PROK -3.46%
PRQR 0.61%
PRTA -3.84%
PRTC -0.08%
PRTG -5.03%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 1.86%
PSTX -6.18%
PTCT -1.73%
PTE -0.82%
PTGX -0.94%
PTIXW -5.10%
PULM 2.63%
PXMD -4.59%
PYPD 0.07%
PYXS -4.08%
QLGN -6.58%
QNCX -2.48%
QNRX -4.84%
QSI -2.50%
QSIAW -3.13%
QTTB -3.97%
QURE -1.76%
RAIN -1.63%
RANI -9.00%
RAPT -4.94%
RARE 1.09%
RCKT -0.87%
REGN 0.69%
RENB 1.26%
REPL 0.68%
RETA 0.02%
REUN -0.89%
REVB -10.42%
REVBU 3.46%
REVBW -38.46%
RGLS 4.39%
RGNX -3.67%
RIGL -11.87%
RLAY -2.32%
RLMD -0.33%
RLYB -3.25%
RNA -1.79%
RNAC 4.43%
RNAZ 1.96%
RNXT -1.74%
ROIV -0.73%
ROIVW 4.56%
RPHM -0.62%
RPRX -0.77%
RPTX -3.67%
RUBY 2.70%
RVLP -32.05%
RVMD 0.86%
RVMDW 5.10%
RVNC -8.56%
RVPH -1.56%
RVPHW -3.43%
RXDX 0.09%
RXRX 0.43%
RYTM 0.52%
RYZB 0.02%
RZLT -9.15%
SABS 0.00%
SABSW 0.25%
SAGE -5.71%
SANA -2.17%
SAVA -2.58%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -8.04%
SCPH -2.94%
SCPS 0.00%
SEEL 2.13%
SEER -1.73%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -4.94%
SGMT -1.43%
SGTX -2.56%
SIOX 22.63%
SLDB -12.39%
SLGL 8.36%
SLN -2.01%
SLNO -2.84%
SLRX 1.24%
SLS -3.31%
SMMT 0.13%
SNDX -1.31%
SNGX -21.60%
SNPX -3.13%
SONN -0.33%
SPPI -0.49%
SPRB 3.68%
SPRC -2.37%
SPRO 0.00%
SRNE -9.09%
SRPT -3.53%
SRRA 0.00%
SRRK -4.04%
SRZN -2.45%
STAB 0.00%
STOK -2.65%
STRO -2.61%
STSA 0.00%
STTK -10.11%
SURF -0.93%
SVRA 3.83%
SWTX 0.94%
SYBX 1.97%
SYRS -0.17%
TALS -0.73%
TARA -5.83%
TARS -2.36%
TBPH -4.22%
TCBP -9.85%
TCDA 0.00%
TCON 21.14%
TCRR 0.00%
TCRT -3.63%
TCRX -7.47%
TECH -1.91%
TENX 3.88%
TERN -3.59%
TFFP 3.68%
TGTX 4.24%
THRX 0.12%
TIL 0.00%
TLC 0.00%
TLSA 2.32%
TNGX -8.77%
TNXP 5.04%
TNYA -7.61%
TPST -1.44%
TRDA 3.72%
TRVI -1.14%
TRVN -2.41%
TSHA -7.33%
TSVT -2.59%
TTNP -0.91%
TVTX 2.18%
TYRA -0.88%
UBX 0.36%
UNCY -26.76%
URGN -5.61%
UTHR 0.03%
VACC 11.36%
VALN -4.35%
VAXX -5.88%
VBIV 3.23%
VBLT -8.77%
VCEL -2.81%
VCNX -6.47%
VCYT -0.92%
VERA 0.97%
VERU -6.67%
VERV -0.95%
VIGL -4.12%
VINC -3.01%
VIR 0.66%
VIRI -5.96%
VIRX -3.22%
VKTX -8.29%
VLON -13.04%
VNDA 2.68%
VOR 0.00%
VRCA -0.98%
VRDN -3.41%
VRNA -4.14%
VRPX -2.58%
VRTX -0.24%
VSTM -5.16%
VTGN 2.79%
VTVT -6.43%
VTYX -4.02%
VXRT -7.63%
VYGR -2.92%
VYNE 0.00%
VYNT 7.78%
WINT -3.24%
WVE -8.45%
XBIO -8.15%
XBIT 5.73%
XCUR -4.08%
XENE -1.10%
XERS -0.47%
XFOR -4.95%
XLO -3.30%
XLRN 0.00%
XNCR -3.68%
XOMA -5.07%
XOMAO 0.36%
XOMAP 0.73%
XRTX -3.29%
YMAB 1.16%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -1.23%
ZNTL -8.70%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-18 Bunn Paul A. Buy 12 500 Stock Option (right to buy)
2024-06-18 Bunn Paul A. Buy 8 333 Common Stock
2024-06-18 Rowinsky Eric K Buy 12 500 Stock Option (right to buy)
2024-06-18 Rowinsky Eric K Buy 8 333 Common Stock
2024-06-18 Kapur Anil Buy 12 500 Stock Option (right to buy)
INSIDER POWER
49.14
Last 100 transactions
Buy: 638 383 | Sell: 236 292
Korrelation (AI algo v.1.1b): Undervalued: 0.41% $2.96 paired level. (Der Algorithmus verfolgt in Echtzeit die Änderungen der am stärksten korrelierten Aktien und gibt eine sofortige Aktualisierung)

Volumen Korrelation

Lang: -0.51 (weak negative)
Kurz: -0.05 (neutral)
Signal:(42.456) Neutral

Verastem Inc Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Verastem Inc Korrelation - Währung/Rohstoff

The country flag -0.72
( moderate negative )
The country flag -0.47
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.80
( moderate negative )
The country flag 0.25
( neutral )

Verastem Inc Finanzdaten

Annual 2023
Umsatz: $0
Bruttogewinn: $-62 000.00 (0.00 %)
EPS: $-3.96
FY 2023
Umsatz: $0
Bruttogewinn: $-62 000.00 (0.00 %)
EPS: $-3.96
FY 2022
Umsatz: $2.60M
Bruttogewinn: $2.48M (95.45 %)
EPS: $-4.58
FY 2021
Umsatz: $2.05M
Bruttogewinn: $2.05M (100.00 %)
EPS: $-0.464

Financial Reports:

No articles found.

Verastem Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Verastem Inc

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of VS-6766 and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 202, which is in Phase 2 trial to evaluate the safety of VS-6766 in combination with defactinib in patients with KRAS and BRAF mutant non-small cell lung cancer following treatment with a platinum-based regimen and immune checkpoint inhibitor. Verastem, Inc. has license agreements with Chugai Pharmaceutical Co., Ltd. for the development, commercialization, and manufacture of products containing VS-6766; and Pfizer Inc. to research, develop, manufacture, and commercialize products containing Pfizer's inhibitors of FAK for therapeutic, diagnostic and prophylactic uses in humans. In addition, it has clinical collaboration agreement with Amgen, Inc. to evaluate the combination of VS-6766 with Amgen's KRAS-G12C inhibitor LUMAKRASTM which in Phase 1/2 trial entitled RAMP 203. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.

Total Execution Time: 1.6552069187164 seconds
Number of API calls: 3
Number of DB calls: 9